greeksoup/ stock research

Healthstream (HSTM) FY2022 results: revenue $267 million, up 3.9% on the year

Healthstream Inc. (HSTM) reported revenue of $267 million for fiscal 2022, the year ended 31 December 2022, up 3.9% on the year before. Net income was $12 million, up 106.9%, and diluted earnings per share $0.39. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2023.

Revenue
$267 million
+3.9% on the year
FY2015FY2022
Operating margin
4.7%
3.1% a year earlier
FY2015FY2022
Net income
$12 million
+106.9% on the year
FY2015FY2022
Diluted EPS
$0.39
+116.7% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue267257245+3.9%
Cost of revenue91.191.089.3+0.1%
Gross profit176166155+6.0%
Gross margin65.8%64.5%63.5%
Research and development44.341.732.3+6.3%
Operating income12.48.115.8+54.5%
Operating margin4.7%3.1%6.5%
Pre-tax income15.67.817.8+100.7%
Income tax3.51.93.7+81.9%
Effective tax rate22.4%24.7%20.9%
Net income12.15.814.1+106.9%
Net margin4.5%2.3%5.8%
Diluted EPS$0.39$0.18$0.44+116.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow51.242.435.9+20.8%
Capital expenditure1.83.42.0-48.3%
Free cash flow49.439.033.9+26.8%
Free cash flow margin18.5%15.2%13.8%
Cash from investing-28.4-25.7-110
Cash from financing-23.7-6.2-20.5
Depreciation and amortisation37.936.830.2+3.1%
Share-based compensation3.65.32.2-33.0%
Buybacks23.15.020.0+362.0%
Dividends paid0.00.00.0
Dividend per share$0.00$0.00n/a
Diluted shares, weighted31m32m32m-2.8%
Shares outstanding at period end31m31m31m-2.3%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity334339334-1.5%
Debt0.00.00.0
Operating lease liabilities23.326.228.5-10.9%
Other liabilities140122138+15.5%
Total liabilities and equity498487500+2.3%
Fixed assets15.517.922.2-13.7%
Goodwill192183178+5.4%
Intangible assets81.689.2101-8.6%
Investments7.95.09.9+56.4%
Cash and equivalents46.046.936.6-1.9%
Receivables36.730.340.7+21.2%
Other assets118115112+2.5%
Total assets498487500+2.3%

10-K for the year ended 31 December 2022, filed 28 February 2023: the filing.